Turn Therapeutics (TTRX) Profit After Tax (2024 - 2026)
Turn Therapeutics (TTRX) posted quarterly Profit After Tax of -$970000.0 for Q1 2026, down 195.24% year-over-year from $1.0 million in Q1 2025, and up 21.6% quarter-over-quarter from -$1.2 million in Q4 2025.
Powered by 
Analysis
Turn Therapeutics (TTRX) Profit After Tax (2024 - 2026) Analysis & Trends
Turn Therapeutics' Profit After Tax history runs 3 years deep, the most recent figure standing at -$970000.0 for Q1 2026.
- In Q1 2026, Profit After Tax fell 195.24% year-over-year to -$970000.0; the TTM figure through Mar 2026 stood at -$4.4 million (changed N/A YoY), while the FY2025 annual figure was -$3.2 million, down 80.95% from the prior year.
- Profit After Tax for Q1 2026 stood at -$970000.0, up from -$1.2 million in the prior quarter.
- The five-year high for Profit After Tax was -$323130.0 in Q4 2024, with the low at -$1.9 million in Q3 2025.
- The 3-year median for Profit After Tax is -$818221.0 (2024), against an average of -$904928.7.
- Peak annual rise in Profit After Tax reached 185.72% in 2025, while the deepest fall reached 282.9% in 2025.
- Turn Therapeutics' Profit After Tax stood at -$323130.0 in 2024, then plunged by 282.9% to -$1.2 million in 2025, then advanced by 21.6% to -$970000.0 in 2026.
- Business Quant data shows TTRX's Profit After Tax at -$970000.0 in Q1 2026, -$1.2 million in Q4 2025, and -$1.9 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 472.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -782.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -644.37 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 237.01 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 164.49 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 81.49 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -16.62 Mn |
| 10 | Turn Therapeutics | 302.05 Mn | 302.05 Mn | - | -5.85 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -5.85 Mn |
| Mar 31, 2026 | -970,972.00 |
| Dec 31, 2025 | 273,150.00 |
| Sep 30, 2025 | -1.90 Mn |
| Jun 30, 2025 | -1.24 Mn |
| Mar 31, 2025 | -328,547.00 |
| Dec 31, 2024 | -323,130.00 |
| Sep 30, 2024 | -666,442.00 |